Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Inhibitory activities of selected Sudanese medicinal plants on Porphyromonas gingivalis and matrix metalloproteinase-9 and isolation of bioactive compounds from Combretum hartmannianum (Schweinf) bark

Authors: Ebtihal Abdalla M. Mohieldin, Ali Mahmoud Muddathir, Tohru Mitsunaga

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Periodontal diseases are one of the major health problems and among the most important preventable global infectious diseases. Porphyromonas gingivalis is an anaerobic Gram-negative bacterium which has been strongly implicated in the etiology of periodontitis. Additionally, matrix metalloproteinases-9 (MMP-9) is an important factor contributing to periodontal tissue destruction by a variety of mechanisms. The purpose of this study was to evaluate the selected Sudanese medicinal plants against P. gingivalis bacteria and their inhibitory activities on MMP-9.

Methods

Sixty two methanolic and 50% ethanolic extracts from 24 plants species were tested for antibacterial activity against P. gingivalis using microplate dilution assay method to determine the minimum inhibitory concentration (MIC). The inhibitory activity of seven methanol extracts selected from the 62 extracts against MMP-9 was determined by Colorimetric Drug Discovery Kit. In search of bioactive lead compounds, Combretum hartmannianum bark which was found to be within the most active plant extracts was subjected to various chromatographic (medium pressure liquid chromatography, column chromatography on a Sephadex LH-20, preparative high performance liquid chromatography) and spectroscopic methods (liquid chromatography-mass spectrometry, Nuclear Magnetic Resonance (NMR)) to isolate and characterize flavogalonic acid dilactone and terchebulin as bioactive compounds.

Results

About 80% of the crude extracts provided a MIC value ≤4 mg/ml against bacteria. The extracts which revealed the highest potency were: methanolic extracts of Terminalia laxiflora (wood; MIC = 0.25 mg/ml) followed by Acacia totrtilis (bark), Ambrosia maritima (aerial part), Argemone mexicana (seed), C. hartmannianum (bark), Terminalia brownii (wood) and 50% ethanolic extract of T. brownii (bark) with MIC values of 0.5 mg/ml. T. laxiflora (wood) and C. hartmannianum (bark) which belong to combretaceae family showed an inhibitory activity over 50% at the concentration of 10 μg/ml against MMP-9. Additionally, MMP-9 was significantly inhibited by terchebulin with IC50 value of 6.7 μM.

Conclusions

To the best of our knowledge, flavogalonic acid dilactone and terchebulin were isolated from C. hartmannianium bark for the first time in this study. Because of terchebulin and some crude extracts acting on P. gingivalis bacteria and MMP-9 enzyme that would make them promising natural preference for preventing and treating periodontal diseases.
Appendix
Available only for authorised users
Literature
1.
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent Jr RL. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25:134–44.CrossRefPubMed
2.
Slots J, Bragd L, Wikstro MM, Dahlen G. The occurrence of actinobacillus actinomycetemcomitans, bacteroides gingivalis bacteroides intermedius in destructive periodontal disease in adults. J Clin periodontal. 1986;13:570–7.CrossRef
3.
Holt SC, Felton J, Brunsvold M, Kornman KS. Implantation of bacteroide gingivalis in non-human primate initiates progression of periodontitis. Science (WashDC). 1988;1239:55–7.CrossRef
4.
Schwartz Z, Goultschin J, Dean DD, Boyan BD. Mechanisms of alveolar bone destruction in periodontitis. Periodontol. 1997;14:158–72.CrossRef
5.
Chang YC, Lai CC, Yang SF, Chan Y, Hsieh YS. Stimulation of matrix metalloproteinases by black-pigmented bacteroides in human pulp and periodontal ligament cell cultures. J Endodon. 2002;28:90–3.CrossRef
6.
Chang YC, Chu SC, Yang SF, Hsieh YS, Yang LC, Huang FM. Examination of the signal transduction pathways leading to activation of gelatinolytic activity by interleukin-1 and Porphyromonas gingivalis in human osteosarcoma cells. J Periodontal Res. 2004;39:168–74.CrossRefPubMed
7.
Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS. Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. J Periodontal Res. 2002;37:196–203.CrossRefPubMed
8.
Varghese J, Tumkur VK, Ballal V, Bhat GS. Antimicrobial effect of Anacardium occidentale leaf extract against pathogens causing periodontal disease. Adv Biosci Biotechnol. 2013;4:15–8.CrossRef
9.
Ohara A, Saito F, Matsuhisa T. Screening of antibacterial activities of edible plants against Streptococcus mutans. Food Sci Technol Res. 2008;14:190–3.CrossRef
10.
Palombo EA. Traditional plant extracts and natural products with activity against oral bacteria: potential application in the prevention and treatment of oral diseases. Evid Based Complement Alternat Med. 2011;201:1–15.CrossRef
11.
Patra JK, Kim ES, Oh K, Kim HJ, Kim Y, Baek KH. Antibacterial effect of crude extract and metabolites of Phytolacca americana on pathogens responsible for periodontal inflammatory diseases and dental caries. BMC Complement Altern Med. 2014;14:343.CrossRefPubMedPubMedCentral
12.
Maydell HJV. Trees and Shrubs of the Sahel. Their Characteristics and Uses, (GTZ) GmbH, Germany, 1990.
13.
Elegami AA, El-Nima EI, El Tohami MS, Muddathir AK. Antimicrobial activity of some species of the family Combretaceae. Phytother Res. 2002;16:555–61.CrossRefPubMed
14.
Eldeen MS, Van Staden J. Anti-inflammatory and mycobacterial activity of leaf extracts of Coleonema album. South Afr J Bot. 2008;74:345–7.CrossRef
15.
Muddathir AM, Mitsunaga T, Kosei Y. Anti-acne activity of tannin-related compounds isolated from Terminalia laxiflora. J Wood Sci. 2013;5:426–31.CrossRef
16.
Hirano Y, Kondo R, Sakai K. 5α-Reductase inhibitory tannin-related compound isolated from Shorea laevifolia. J Wood Sci. 2003;49:339–42.CrossRef
17.
Lin TC, Nonaka GI, Nishioka I, Ho FC. Tannins and related compounds, CII. Structures of terchebulin, an ellagitannin having a novel tetraphenyl carboxylic acid (terchebulic acid) moiety, and biogenetically related tannins from Terminalia chebula Retz. L. Chem Pharm Bull. 1990;38:3004–8.CrossRef
18.
Iwaki K, Koya-Miyata S, Kohno K, Ushio S, Fukuda S. Antimicrobial activity of Polygonum tinctorium lour: extract against oral pathogenic bacteria. J Nat Med. 2006;60:121–5.CrossRef
19.
Eloff JN. Antibacterial activity of Marula (Sclerocarya birrea (a. Rich) Hochst. Subsp. Caffra (Sond) Kokwaro) (Anacardiaceae) bark and leaves. J Ethnopharmacol. 2001;76:305–8.CrossRefPubMed
20.
Choi JS1, Ha YM, Joo CU, Cho KK, Kim SJ, Choi IS. Inhibition of oral pathogens and collagenase activity by seaweed extracts. J Environ Biol. 2012;33:115–21.PubMed
21.
22.
Gulati V, Harding IH, Palombo EA. Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia. BMC Complement Altern Med. 2012;12:77.CrossRefPubMedPubMedCentral
23.
Muddathir AM, Mitsunaga T. Evaluation of anti-acne activity of selected Sudanese medicinal plants. J Wood Sci. 2013;59:73–9.CrossRef
24.
Eloff JN, Katerel DR, McGaw LJ. The biological activity and chemistry of the southern African Combretaceae. J Ethnopharmacol. 2008;119:686–99.CrossRefPubMed
25.
Martini ND, Katerere DRP, Eloff JN. Biological activity of seven antibacterial flavonoids isolated from Combretum erythrophyllum (Combretaceae). J Ethnopharmacol. 2004;93:207–12.CrossRefPubMed
26.
Basile A, Giordano S, Lopez-Saez JA, Cobianchi RC. Antibacterial activity of pure flavonoids isolated from mosses. Phytochemistry. 1999;52:1479–82.CrossRefPubMed
27.
Eldeen IMS, Van SJ. In vitro pharmacological investigation of extracts from some trees used in Sudanese traditional medicine. South Afr J Bot. 2007;73:435–40.CrossRef
28.
Zanatta FB, Antoniazzi RP, Rösing CK. Staining and calculus formation after 0.12% chlorhexidine rinses in plaque-free and plaque covered surfaces: a randomized trial. J Appl Oral Sci. 2010;18:515–21.CrossRefPubMedPubMedCentral
29.
Amanlou M, Beitollahi JM, Abdollahzadeh S, Tohidast-Ekrad Z. Miconazole gel compared with Zataria multiflora Boiss. Gel in the treatment of denture stomatitis. Phytother Res. 2006;20:966–9.CrossRefPubMed
30.
Kitano S, Irimura K, Sasaki T, Abe N, Baba A, Miyake Y, Katunuma N, Yamamoto K. Suppression of gingival inflammation induced by Porphyromonas gingivalis in rats by leupeptin. Jpn J Pharmacol. 2001;85:84–91.CrossRefPubMed
31.
Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MH. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review. J Clin Periodontol. 2004;31:697–707.CrossRefPubMed
32.
Kusumoto T, Nakabayashi T, Kida H, Miyashiro H, Hattori M, Namba T. Screening of various plant extracts used in Ayurvedic medicine for inhibitory effects on human immunodeficiency virus type 1 (HIV-1) protease. Phytother Res. 1995;9:180–4.CrossRef
33.
Dell'Agli M, Galli GV, Bulgari M, Basilico N, Romeo S, Bhattacharya D, Taramelli D, Bosisio E. Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria. Malar J. 2010;9:208.CrossRefPubMedPubMedCentral
34.
Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol. 2004;48:411–24.CrossRefPubMed
35.
Seigler DS. Phytochemistry of Acacia-sensu lato. Biochem Syst Ecology. 2003;31:845–73.CrossRef
36.
Kosei Y, Mitsunaga T, Ali MM. Screening for melanogenesis-controlled agents using Sudanese medicinal plants and identification of active compounds in the methanol extract of Terminalia brownii bark. J Wood Sci. 2016;62:285–93.CrossRef
37.
El Ghazali GEB, El Tohamy MS, El Egami AB. Medicinal plants of the Sudan. Part III. Sudan: Medicinal Plants of the White Nile Province Khartoum University Press; 1994.
38.
Al Magboul AZ, Bashir AK, Salih AM, Farouk A, Khalid SA. Antimicrobial activity of certain Sudanese plants used in folkloric medicine: screening for antibacterial activity (V). Fitoterapia. 1988;59:57–62.
39.
Ali H, König GM, Khalid SA, Wright AD, Kaminsky R. Evaluation of selected Sudanese medicinal plants for their in vitro activity against hemoflagellates, selected bacteria, HIV-1-RT and tyrosine kinase inhibitory, and for cytotoxicity. J Ethnopharmacol. 2002;83:219–28.CrossRefPubMed
40.
Marquis A, Genovese S, Epifano F, Grenier D. The plant coumarins auraptene and lacinartin as potential multifunctional therapeutic agents for treating periodontal disease. BMC Complement Altern Med. 2012;2:80.
41.
Silva O, Viegas S, de Mello-Sampayo C, Costa MJ, Serrano R, Cabrita J, Gomes ET. Anti-Helicobacter pylori activity of Terminalia macroptera root. Fitoterapia. 2012;83:872–6.CrossRefPubMed
42.
Ohtsuki T, Yokosawa E, Koyano T, Preeprame S, Kowithayakorn T, Sakai S, Toida T, Ishibashi M. Quinic acid esters from Pluchea indica with collagenase, MMP-2 and MMP-9 inhibitory activities. Phytother Res. 2008;22:264–6.CrossRefPubMed
43.
Arabaci T, Türkez H, Çanakçi CF, Özgöz M. Assessment of cytogenetic and cytotoxic effects of chlorhexidine digluconate on cultured human lymphocytes. Acta Odontol Scand. 2013;71:1255–60.CrossRefPubMed
44.
Shuaibu MN, Wuyep PA, Yanagi T, Hirayama K, Tanaka T, Kouno I. The use of microfluorometric method for activity-guided isolation of antiplasmodial compound from plant extracts. Parasitol Res. 2008;102:1119–27.CrossRefPubMed
45.
Mossa JS, Tarig M, Mohsin A, Rafatulla S. Pharmacological studies on aerial parts of Calotropis procera. Am J Chin Med. 1991;19:223–31.CrossRefPubMed
46.
El Ghazali GEB, Bari EA, Bashir AK, Salih AM. Medicinal plants of Sudan part II. Medicinal plants of eastern Nuba Mountains. Khartoum: National Council for Research; 1987.
47.
El Ghazali GEB, El Tohami MS, El Egami AA, Abdalla WE, Galal M. Medicinal plants of the Sudan part IV. Medicinal plants of north Kordofan. Khartoum: National Council for Research; 1997.
48.
El Ghazali GEB, Abdalla WE, Khalid HE, Khalafalla MM, Hamad AA. Medicinal plants of the Sudan part V. Medicinal plants of Ingassana area. Khartoum: National Council for Research; 2003.
49.
El Kamali HM, El Khalifa KF. Folk medicinal plants of riverside forests of the southern Blue Nile district. Sudan Fitoterapia. 1999;70:493–7.CrossRef
50.
Hussein G, Miyashiro H, Nakamura N, Hattori M, Kawahata T, Otake T. Inhibitory effects of Sudanese plant extracts on HIV-1 replication and HIV-1 protease. Phytother Res. 1999;13:31–6.CrossRefPubMed
51.
Nour AM, Khalid SA, Kaiser M, Brun R, Abdallah WE, Schmidt TJ. The antiprotozoal activity of sixteen asteraceae species native to Sudan and bioactivity-guided isolation of xanthanolides from Xanthium brasilicum. Planta Med. 2009;75:1363–8.CrossRefPubMed
52.
Dahab MM, Koko WS, Osman EE. In vitro antitrichomonal activity of Xanthium brasilicum vell and Argemone mexicana L different extracts. J Med Plant Res. 2011;5:151–5.
53.
Rahman MA, Mossa JS, AL-Said MS, AL-Yahya MA. Medicinal plant diversity in the flora of Saudi Arabia 1: a report on seven plant families. Fitoterapia. 2004;75:149–61.CrossRefPubMed
54.
Kinghorn AD, Chai HB, Sung CK, Keller WJ. The classical discovery approach to defining bioactive constituent of botanicals. Fitoterapia. 2011;82:71–9.CrossRefPubMed
55.
Musa S, Abdelrasool F, El E, Ahmed L, Mahmoud A, Yagi S. Ethnobotanical study of medicinal plants in the Blue Nile state, South-eastern Sudan. J Med Plants Res. 2011;5:4287–97.
56.
Ogbazghi W, Bein E. Assessment of non-wood forest products and their role in the livelihoods of rural communities in the gash-Barka region, Eritrea. Drylands Coordination Group Report. 2006;40:26–7.
57.
Mahmoud AA, Ahmed AA, El Bassuony AA. A new chlorosesquiterpene lactone from Ambrosia maritima. Fitoterapia. 1999;70:575–8.CrossRef
58.
Hatil HE. Medicinal plants in east and central Africa: challenges and constraints. Ethnobot leaflet. 2009;13:364–9.
59.
Ferraz AC, Angelucci ME, Da Costa ML, Batista IR, De Oliveira BH, Da Cunha C. Pharmacological evaluation of ricinine, a central nervous system stimulant isolated from Ricinus communis. Pharmacol Biochem Behav. 1999;63:367–75.CrossRefPubMed
60.
Holfelder MG, Steck M, Komor E, Seifert K. Ricinine in phloem sap of Ricinus communis. Phytochemistry. 1998;47:1461–3.CrossRef
61.
Duke JA. Medicinal plants of the bible. Owerri, NY: Trado-Medic Books; 1983.
62.
63.
Louhaichi M, Salkini AK, Estita HE, Belkhir S. Initial assessment of medicinal plants across the Libyan Mediterranean coast. Adv Environ Biol. 2011;5:359–70.
64.
El Ghazali GEB. Medicinal plants of Sudan part I. Khartoum: Medicinal Plants of Erkawit, National Council for Research; 1986.
65.
Masoko P, Gololo SS, Mokgotho MP, Eloff JN, Howard RL, Mampuru LJ. Evaluation of the antioxidant, antibacterial, and antiproliferative activities of the acetone extract of the roots of Senna italica (Fabaceae). Afr J Tradit Complement Altern Med. 2010;7:138–48.
66.
Hatil HE. Effect of certain medicinal plants extracts against storage pest, Tribolium castaneum Herbst. Am Eurasian J Sustain Agric. 2009;3:139–42.
67.
El Kheir YM, Salih MH. Investigation of certain plants used in Sudanese folk medicine. Fitoterapia. 1980;51:143–7.
68.
El Kamali HM, Khalid SA. The most common herbal remedies in Central Sudan. Fitoterapia. 1996;57:301–6.
69.
Neuwinger DH. African traditional medicine. A dictionary of plant use and application. Stuttgart, Germany: Med. Pharm. Pub; 2000.
Metadata
Title
Inhibitory activities of selected Sudanese medicinal plants on Porphyromonas gingivalis and matrix metalloproteinase-9 and isolation of bioactive compounds from Combretum hartmannianum (Schweinf) bark
Authors
Ebtihal Abdalla M. Mohieldin
Ali Mahmoud Muddathir
Tohru Mitsunaga
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1735-y

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue

Research article

Patient benefit of dog-assisted interventions in health care: a systematic review

Research article

ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs

Research article

Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections

Research article

Effects of cold sensitivity in the extremities on circulating adiponectin levels and metabolic syndrome in women

Research article

Effects of the combined extracts of Herba Epimedii and Fructus Ligustrilucidi on airway remodeling in the asthmatic rats with the treatment of budesonide

Research article

Traditional Arabic & Islamic medicine: validation and empirical assessment of a conceptual model in Qatar